Antibody drug to be sold commercially amid dwindling federal supply

Indianapolis-based Eli Lilly will sell its COVID-19 monoclonal antibody treatment to healthcare systems, hospitals and states this month, The Wall Street Journal reported Aug. 3. 

Read the full post at Becker's Hospital Review - Healthcare News